PubMed Health⌕ Search

PubMed · 2814260

[Autologous transfusion].

Abstract

Transfusions of autologous blood--the patient's own blood--do not transmit infections and have no immunological consequences. Autologous transfusion includes intraoperative or postoperative salvage of blood losses, as well as transfusion of blood collected immediately before (acute normovolaemic haemodilution) or weeks before surgery in a predonation programme. Salvaged blood can be a good substitute for red cells. Small volume blood salvage can be achieved with simple devices, such as an anticoagulant liner in a rigid canister connected to a wall vacuum line. Filtration is mandatory. For larger volumes of haemorrhage, automated systems operating by semi-continuous flow techniques are yielding standardised washed red blood cell concentrates decreasing the frequency of coagulopathies. It is generally agreed that salvage of blood potentially infected or containing neoplastic cells is contraindicated. In preoperative autologous transfusion programmes, the decision to collect the patient's blood is shared by the anaesthetist and the transfusionist. Anaemia and the possibility of bacteraemia are contraindications. With the present red cell preservative solutions, up to 5 autologous units can be collected in the weeks preceding surgery and stored at 4 degrees C. After the third weekly collection, erythropoiesis stimulation is such that provided the iron intake in adequate collected red cells can be reconstituted within less than a week. Preoperative and intraoperative autologous transfusions are complementary. In the often irreplaceable homologous transfusion as well as in its autologous alternative, medical cooperation and rigorous indications concur in a global blood conservation programme.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

L Noël. 1989-09-11. [Autologous transfusion].. https://pubmed.ncbi.nlm.nih.gov/2814260/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Autologous serum therapy of the ocular surface with novel delivery by platelet concentrate gel.

Application of autologous serum to treat a multitude of ocular surface diseases and conditions is a relatively new technique that has gained popularity over the past 10 years. This review focuses on the use of topical autologous serum and a new platelet gel delivery technique that utilizes autologous platelet concentrate mixed with calcium chloride and thrombin for gelling serum, which can then be applied easily to the corneal surface. Residual platelet serum concentrate can be mixed with artificial tears that are capable of gelling in a 25% concentrate, which is then used by the patient postoperatively. A review of the literature identifies various concentrations of autologous serum, frequency of application, and storage criteria.

Blood Transfusion, Autologous↗

Pneumonia as a complication of blood product transfusion in the critically ill: transfusion-related immunomodulation (TRIM).

BACKGROUND: An increased risk of postoperative infection (including pneumonia) attributable to the receipt of allogeneic blood transfusion has been investigated as a possible manifestation of transfusion-related immunomodulation (TRIM) in 16 randomized controlled trials (RCTs) and approximately 40 observational studies. OBJECTIVES: This review categorizes RCTs and observational studies with regard to the inference that they permit about possible mediators of TRIM-allogeneic white cells (WBCs), WBC-derived soluble mediators, and/or allogeneic plasma-and examines whether the totality of the clinical evidence supports an association between allogeneic blood transfusion and postoperative infection. RESULTS: When all available studies are considered together in meta-analyses, three types of studies show no increased risk of postoperative infection in association with allogeneic blood transfusion: a) RCTs comparing recipients of buffy-coat-reduced and prestorage-filtered, WBC-reduced allogeneic red cells; b) RCTs comparing recipients of allogeneic and autologous blood; and c) observational studies comparing patients transfused before and after implementation of WBC reduction. RCTs comparing recipients of nonbuffy-coat-reduced and WBC-reduced red blood cells may point to a TRIM effect, but they cannot yet be subjected to formal meta-analysis. CONCLUSIONS: No overwhelming clinical evidence has been presented to establish the existence of a TRIM effect that relates allogeneic blood transfusion to postoperative infection.

Blood Transfusion, Autologous↗